SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-22-274089
Filing Date
2022-10-31
Accepted
2022-10-31 17:28:31
Documents
4
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A d327928dpre14a.htm PRE 14A 256494
2 GRAPHIC g327928g01a01.jpg GRAPHIC 38747
3 GRAPHIC g327928g08j00.jpg GRAPHIC 309617
4 GRAPHIC g327928g09g00.jpg GRAPHIC 191858
  Complete submission text file 0001193125-22-274089.txt   997527
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36912 | Film No.: 221347271
SIC: 2836 Biological Products, (No Diagnostic Substances)